Resproly
Zhuhai
About Resproly
Resproly is a research and development, production and sales of formula and equipment for respiratory inhalation. An integrated enterprise that focuses on multiple clinically demanding treatment areas such as Asthma, Chronic Obstructive Pulmonary Disease (COPD), Diabetes, and Parkinson's Disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $38.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2022)
- Website: resproly.com
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/resproly-111181 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.